TOTAL NEOADJUVANT THERAPY
Clinical trials for TOTAL NEOADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new TOTAL NEOADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for TOTAL NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat rectal cancer: major trial tests powerful drug combo
Disease control Not yet recruitingThis large national study aims to see if adding immunotherapy drugs to the standard pre-surgery treatment (chemotherapy and radiation) works better for people with high-risk rectal cancer. It will also compare two different lengths of radiation treatment. The goal is to shrink tu…
Matched conditions: TOTAL NEOADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Could a popular weight loss drug help beat rectal cancer?
Disease control Not yet recruitingThis study is testing if adding a weight loss medication (a GLP-1 receptor agonist like semaglutide) to standard pre-surgery cancer treatment improves results for overweight patients with locally advanced rectal cancer. Researchers will compare two groups: one gets the standard t…
Matched conditions: TOTAL NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: St. James's Hospital, Ireland • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC